During the past decade, University of Arizona conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Arizona" #1 sponsor was "Astellas Pharma Global Development, Inc." with 1 trials, followed by "Engage Therapeutics, Inc." with 1 trials sponsored, "Mayo Clinic" with 1 trials sponsored, "Mercy Health Ohio" with 1 trials sponsored and "Soligenix" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Arizona" #1 collaborator was "AtCor Medical, Inc." with 1 trials as a collaborator, "Baylor Scott and White Health" with 1 trials as a collaborator, "Columbia University" with 1 trials as a collaborator, "Digestive Health Foundation" with 1 trials as a collaborator and "Mayo Clinic" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "University of Arizona" are "COVID-19" (1 trials), "Chronic Liver Disease" (1 trials), "Cirrhosis, Liver" (1 trials), "Cutaneous T-Cell Lymphoma" (1 trials) and "Epilepsy" (1 trials). Many other conditions were trialed in "University of Arizona" in a lesser frequency.

Most popular intervention types in "University of Arizona" are "Drug" (3 trials), "Device" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "DEB-TACE" (1 trials), "Placebo" (1 trials), "Placebos" (1 trials), "Prospective Chart Review" (1 trials) and "SGX301 (synthetic hypericin)" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Arizona" are 8 trials for "All" genders.

Currently, there are NaN active trials in "University of Arizona". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in University of Arizona, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Arizona, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".